Font Size:
a
A
A
Keyword [EML4]
Result: 21 - 40 | Page: 2 of 3
21.
Role Of Stat3/Survivin Signaling Pathway In The EML4-ALK Positive Lung Adenocarcinoma Cell-Line H2228 Before And After Crizotinib Induced Resistance
22.
Influence Of BIM Signaling Pathway In EML4-ALK Positive Lung Adenocarcinoma Cell-Line H2228 After Crizotinib Induced Resistance
23.
Relations Of EML4-ALK Fusion Gene And The MRNA Expression Of TYMS In Patients With Lung Adenocarcinoma Tissue
24.
Study Of EML4-ALK Fusion Gene In The Primary And Metastases Tumor Tissues And The Serum Of VEGF In Non-small Cell Lung Cancer Patients
25.
The Structure Analysis Of EML4-ALK Fusion Genelociand The Association Study Between-308 Signal Nucleotidepolymorphism(SNP) Of TNF-α Gene And Primary Lung Cancer
26.
The Association Analysis Between Driver Gene Mutations Of EGFRKRASEML4-ALK And Clinical Features Of Patients Of Lung Cancer
27.
ALK Associated NSCLC:Study And Perspective Of Immunohistochemical Screening And EML4-ALK Fusion Heterogeneity
28.
Establishment Of Crizotinib-resistant Cell Line H3122 Of Non-small Cell Lung Cancer And Underlying Resistance Mechanisms
29.
Role Of MTOR Signaling Pathway In 17-DMAG Overcoming Acquire Resistance To Alectinib In EML4–ALK Positive Lung Cancer Cell Line H3122
30.
Efficacy Of Crizotinib In Advanced EML4-ALK Positive Non-small Cell Lung Cancer
31.
By Pass Signaling Pathways Activation Mediated Resistance To Alectinib In EML4-ALK Fusion Gene Positive Lung Cancer Cell Line H3122
32.
Noninvasive Detection Of EML4-ALK Fusion Gene
33.
Detection Of EML4-ALK Fusion Gene And Analysis Of Its Clinical Features In NSCLC Patients With EML4-ALK Fusion Gene
34.
An Exploratory Study On Screening Of Spcific Peptides In Patients With ALK+NSCLC And Crizotinib Efficacy Related Peptides By Serum Mass Spectrum
35.
The Effects And Methylation Status Of SOCS1 And SOCS3 Gene Promoter In EML4-ALK Positive H2228 Lung Cancer Cells
36.
Correlation Study Of EGFR And ALK Expression In Lung Adenocarcinoma Based On Spectral CT Parameters
37.
The Anti-tumor Effect Of A Novel ALK/ROS1 Dual Target Inhibitors ZX-29 In Vitro And The Mechanism Of Drug Resistance Result From By ROS1 Mutation
38.
Research On The Reference Material For EML4-ALK Fusion Gene Detection Based On CRISPR/CAS9 Technology
39.
Expression And Significance Of PD-1 And PD-L1 In Non-Small Cell Lung Cancer In Yunnan Xuanwei Region
40.
Meteormin Restore Alectinib Sensitivty In H3122 Cells Through Inhibition Of IGF-1R/PI3K/AKT/mTOR Signalingpathway
<<First
<Prev
Next>
Last>>
Jump to